REAL-WORLD DATA OF THE USE OF RIVAROXABAN IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
Sultan, Noemie
Tran, Thai
Remy, Meredith
Pelland-Marcotte, Marie-Claude
机构：
[1] CHU St Justine, Dept Pediat, Montreal, PQ, Canada
[2] CHU Quebec Ctr Mere Enfant Soleil, Dept Pediat, Montreal, PQ, Canada
[3] CHU Quebec Ctr Mere Enfant Soleil, Dept Pediat, Quebec City, PQ, Canada
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [31] A real-world study of different doses of rivaroxaban in patients with nonvalvular atrial fibrillation
    Yan, Xinsheng
    Zhang, Litao
    Zhang, Dan
    Wang, Xiaosu
    MEDICINE, 2024, 103 (17) : E38053
  • [32] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [33] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [34] RIVAROXABAN PRECISION DOSING STRATEGY FOR REAL-WORLD ATRIAL FIBRILLATION PATIENTS.
    Powell, J.
    Konicki, R.
    Weiner, D.
    Patterson, J.
    Gonzalez, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S100 - S101
  • [35] Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting
    Fontaine, Gabriel V.
    Mathews, Katy D.
    Woller, Scott C.
    Stevens, Scott M.
    Lloyd, James F.
    Evans, R. Scott
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 665 - 672
  • [36] Real-world rivaroxaban use in fragile Asian patients with atrial fibrillation: The impact of plasma concentration on clinical outcomes
    Wang, Zhe
    Zhu, Long-Yang
    Yu, Lu-Yao
    Chen, Wen-Qian
    Chen, Yi-Nong
    Li, Qing
    Liu, Ying
    Jiao, Si-Qi
    Zhai, Zhen-Guo
    Zhao, Li
    Sun, Yi-Hong
    THROMBOSIS RESEARCH, 2022, 218 : 189 - 191
  • [37] The Emicizumab Switch: Real-World Data of 251 Pediatric Patients from the Pednet Registry
    Van der Zwet, Konrad
    de Kovel, Marloes
    Motwani, Jayashree
    Van Geet, Christel
    Nolan, Beatrice
    Glosli, Heidi
    Kenet, Gili
    Fischer, Kathelijn
    BLOOD, 2022, 140 : 8442 - 8443
  • [38] Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis
    Sharmila Raghunandan
    Lev Gorfinkel
    Brandi Bratrude
    Yvonne Suessmuth
    Kyle Hebert
    Donna Neuberg
    Kirsten M. Williams
    Michelle L. Schoettler
    Amelia A. Langston
    Leslie S. Kean
    Muna Qayed
    John Horan
    Benjamin K. Watkins
    Bone Marrow Transplantation, 2023, 58 : 1260 - 1263
  • [39] Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis
    Raghunandan, Sharmila
    Gorfinkel, Lev
    Bratrude, Brandi
    Suessmuth, Yvonne
    Hebert, Kyle
    Neuberg, Donna
    Williams, Kirsten M.
    Schoettler, Michelle L.
    Langston, Amelia A.
    Kean, Leslie S.
    Qayed, Muna
    Horan, John
    Watkins, Benjamin K.
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1260 - 1263
  • [40] Use of Real-World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of Age
    Lukka, Pradeep B.
    Woods, Megan
    Chhim, Rebecca
    Phelps, Stephanie J.
    Wheless, James W.
    Meibohm, Bernd
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (07): : 881 - 888
12345